Adam Kaye ^Investor

Adam Kaye is a seasoned Managing Director at Sixth Street, a global finance and investment firm with over $70 billion in assets under management. With a background in structured capital for healthcare companies, he has held key roles at Hayfin Capital Management, New Health Capital Partners, and New Leaf Venture Partners. Adam's expertise spans venture capital, investment banking, and board memberships at ConcertAI. He holds a BBA in Finance and Consulting from Emory University and an MS in Biology from New York University. Adam is a member of industry groups like DOC New York Chapter and Global Drug Development Leaders.